Leader MB - Search Results

1

Altered expression of the p53-regulated proteins, p21Waf1/Cip1, MDM2, and Bax in ultraviolet-irradiated human skin.

O'Grady A, Kay EW, McKenna DB, Bennett MA, Murphy GM, Leader MB. O'Grady A, et al. Among authors: leader mb. Hum Pathol. 1998 Jun;29(6):559-64. doi: 10.1016/s0046-8177(98)80003-8. Hum Pathol. 1998. PMID: 9635674

2

Replication error phenotype, clinicopathological variables, and patient outcome in Dukes' B stage II (T3,N0,M0) colorectal cancer.

Curran B, Lenehan K, Mulcahy H, Tighe O, Bennett MA, Kay EW, O'Donoghue DP, Leader M, Croke DT. Curran B, et al. Gut. 2000 Feb;46(2):200-4. doi: 10.1136/gut.46.2.200. Gut. 2000. PMID: 10644313 Free PMC article.

3

Loss of p16 (INK4A) expression is associated with allelic imbalance/loss of heterozygosity of chromosome 9p21 in microdissected malignant peripheral nerve sheath tumors.

Sabah M, Cummins R, Leader M, Kay E. Sabah M, et al. Appl Immunohistochem Mol Morphol. 2006 Mar;14(1):97-102. doi: 10.1097/01.pai.0000143787.80564.f5. Appl Immunohistochem Mol Morphol. 2006. PMID: 16540739

4

Immunoreactivity of p53, Mdm2, p21(WAF1/CIP1) Bcl-2, and Bax in soft tissue sarcomas: correlation with histologic grade.

Sabah M, Cummins R, Leader M, Kay E. Sabah M, et al. Appl Immunohistochem Mol Morphol. 2007 Mar;15(1):64-9. doi: 10.1097/01.pai.0000201809.43554.ed. Appl Immunohistochem Mol Morphol. 2007. PMID: 17536310

5

Molecular genetic analysis of the BRCA2 tumor suppressor gene region in cutaneous squamous cell carcinomas.

Gray SE, Kay E, Leader M, Mabruk M. Gray SE, et al. J Cutan Pathol. 2008 Jan;35(1):1-9. doi: 10.1111/j.1600-0560.2007.00760.x. J Cutan Pathol. 2008. PMID: 18095987

6

Analysis of FHIT allelic imbalance/loss of heterozygosity and FHIT expression in cutaneous squamous cell carcinomas.

Gray SE, Kay E, Leader M, Mabruk M. Gray SE, et al. J Cutan Pathol. 2008 Sep;35(9):816-25. doi: 10.1111/j.1600-0560.2007.00913.x. Epub 2008 May 20. J Cutan Pathol. 2008. PMID: 18494825

7

The different telomere lengths in basal and squamous cell carcinomas also differ between the nontransplant and renal transplant population.

Perrem K, Lynch A, Al Nooh F, Leader M, Elaine Kay. Perrem K, et al. Hum Pathol. 2008 Jul;39(7):1034-41. doi: 10.1016/j.humpath.2007.11.008. Epub 2008 May 14. Hum Pathol. 2008. PMID: 18482746

8

The higher incidence of squamous cell carcinoma in renal transplant recipients is associated with increased telomere lengths.

Perrem K, Lynch A, Conneely M, Wahlberg H, Murphy G, Leader M, Kay E. Perrem K, et al. Hum Pathol. 2007 Feb;38(2):351-8. doi: 10.1016/j.humpath.2006.08.019. Epub 2006 Nov 28. Hum Pathol. 2007. PMID: 17134737

9

Aberrant expression of the Rb pathway proteins in soft tissue sarcomas.

Sabah M, Cummins R, Leader M, Kay E. Sabah M, et al. Appl Immunohistochem Mol Morphol. 2006 Dec;14(4):397-403. doi: 10.1097/01.pai.0000190176.06200.68. Appl Immunohistochem Mol Morphol. 2006. PMID: 17122635

10

Analysis of p16 expression and allelic imbalance / loss of heterozygosity of 9p21 in cutaneous squamous cell carcinomas.

Gray SE, Kay E, Leader M, Mabruk M. Gray SE, et al. J Cell Mol Med. 2006 Jul-Sep;10(3):778-88. doi: 10.1111/j.1582-4934.2006.tb00437.x. J Cell Mol Med. 2006. PMID: 16989737 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results